Dr. Reddy’s Q4 and FY16 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Dr. Reddys Labs (RDY) Reports Q4 EPS of $0.07
May 12, 2016 9:19 AM EDTDr. Reddys Labs (NYSE: RDY) reported Q4 EPS of $0.07, versus $0.46 reported last year. Revenue for the quarter came in at $567 billion, versus $584 billion reported last year.
For earnings history and earnings-related data on Dr. Reddys Labs (RDY) click here.
... More